Total planned funding: $1,161,952,662
Allocations
Countries/Regions
| Nigeria | $278,016,038 |
| Mozambique | $143,882,185 |
| Tanzania | $136,318,443 |
| Zambia | $130,821,521 |
| Uganda | $97,124,821 |
| Côte d'Ivoire | $82,994,542 |
| Zimbabwe | $70,216,610 |
| Kenya | $45,608,678 |
| Rwanda | $45,319,885 |
| Vietnam | $33,858,620 |
| Haiti | $29,274,075 |
| Ethiopia | $23,329,791 |
| South Africa | $11,155,699 |
| Cameroon | $10,170,000 |
| Democratic Republic of the Congo | $6,308,301 |
| Botswana | $4,859,491 |
| Burundi | $2,333,074 |
| South Sudan | $2,138,349 |
| Namibia | $1,983,187 |
| Eswatini | $1,774,702 |
| Guyana | $1,599,493 |
| Lesotho | $1,200,000 |
| Malawi | $1,100,000 |
| Indonesia | $531,157 |
| Angola | $34,000 |
| Central America Region | $0 |
| Dominican Republic | $0 |
Organizational Types
| Private Contractor | $1,161,952,662 |
Program Areas
| Treatment | $1,161,952,662 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $854,041,517 |
| HTXS: Treatment: Adult Treatment | $272,066,979 |
| PDTX: Treatment: Pediatric Treatment | $35,844,166 |
Top Partner Programs
Chemonics International:
$44,398,796
View countries
Deloitte Consulting Limited:
$30,706,915
View countries
Abt Associates:
$27,269,506
View countries